These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
632 related articles for article (PubMed ID: 30047189)
1. Comorbidity in psoriatic arthritis and rheumatoid arthritis. Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L Intern Med J; 2018 Nov; 48(11):1360-1368. PubMed ID: 30047189 [TBL] [Abstract][Full Text] [Related]
2. Investigating Dimensions of Stiffness in Rheumatoid and Psoriatic Arthritis: The Australian Rheumatology Association Database Registry and OMERACT Collaboration. Sinnathurai P; Bartlett SJ; Halls S; Hewlett S; Orbai AM; Buchbinder R; Henderson L; Hill CL; Lassere M; March L J Rheumatol; 2019 Nov; 46(11):1462-1469. PubMed ID: 30936277 [TBL] [Abstract][Full Text] [Related]
3. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative. Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B J Rheumatol; 2015 Oct; 42(10):1767-80. PubMed ID: 26178281 [TBL] [Abstract][Full Text] [Related]
4. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study. Lee JL; Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L Arthritis Res Ther; 2018 Aug; 20(1):171. PubMed ID: 30086795 [TBL] [Abstract][Full Text] [Related]
5. Intense symptoms of pain are associated with poor sleep, fibromyalgia, depression and sleep apnea in patients with rheumatoid arthritis and psoriatic arthritis. A register-based study. Weman L; Salo H; Kuusalo L; Huhtakangas J; Vähäsalo P; Backström M; Kärki J; Sokka-Isler T Joint Bone Spine; 2024 Sep; 91(5):105744. PubMed ID: 38795765 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink. Edson-Heredia E; Zhu B; Lefevre C; Wang M; Barrett A; Bushe CJ; Cox A; Wu JJ; Maeda-Chubachi T J Eur Acad Dermatol Venereol; 2015 May; 29(5):955-63. PubMed ID: 25352213 [TBL] [Abstract][Full Text] [Related]
7. Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis. Nas K; Karkucak M; Durmus B; Karatay S; Capkın E; Kaya A; Ucmak D; Akar ZA; Cevik R; Kilic E; Kilic G; Ozgocmen S Int J Rheum Dis; 2015 Nov; 18(8):873-9. PubMed ID: 26173043 [TBL] [Abstract][Full Text] [Related]
8. Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study. Stouten V; Pazmino S; Verschueren P; Mamouris P; Westhovens R; de Vlam K; Bertrand D; Van der Elst K; Vaes B; De Cock D RMD Open; 2021 Jun; 7(2):. PubMed ID: 34158353 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Husted JA; Thavaneswaran A; Chandran V; Eder L; Rosen CF; Cook RJ; Gladman DD Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1729-35. PubMed ID: 21905258 [TBL] [Abstract][Full Text] [Related]
10. Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis. Lauper K; Courvoisier DS; Chevallier P; Finckh A; Gabay C Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1756-1763. PubMed ID: 29609199 [TBL] [Abstract][Full Text] [Related]
11. Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis. Jin S; Li M; Fang Y; Li Q; Liu J; Duan X; Liu Y; Wu R; Shi X; Wang Y; Jiang Z; Wang Y; Yu C; Wang Q; Tian X; Zhao Y; Zeng X; Arthritis Res Ther; 2017 Nov; 19(1):251. PubMed ID: 29141688 [TBL] [Abstract][Full Text] [Related]
12. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings. Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study. Grellmann C; Dombrowsky W; Fabricius V; Suruki R; Sheahan A; Joeres L Adv Ther; 2021 Jan; 38(1):366-385. PubMed ID: 33128201 [TBL] [Abstract][Full Text] [Related]
14. Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis. Radner H; Lesperance T; Accortt NA; Solomon DH Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1510-1518. PubMed ID: 27998029 [TBL] [Abstract][Full Text] [Related]
15. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study. Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730 [TBL] [Abstract][Full Text] [Related]
16. Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Labitigan M; Bahče-Altuntas A; Kremer JM; Reed G; Greenberg JD; Jordan N; Putterman C; Broder A Arthritis Care Res (Hoboken); 2014 Apr; 66(4):600-7. PubMed ID: 24115739 [TBL] [Abstract][Full Text] [Related]
17. Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study. Bengtsson K; Jacobsson LT; Rydberg B; Kvist G; Torstenson T; Dehlin M; Hilme E; Lindhé A; Wallerstedt SM; Forsblad-d'Elia H BMC Musculoskelet Disord; 2016 Dec; 17(1):499. PubMed ID: 27955647 [TBL] [Abstract][Full Text] [Related]
18. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study. Smolen JS; Gladman D; McNeil HP; Mease PJ; Sieper J; Hojnik M; Nurwakagari P; Weinman J RMD Open; 2019; 5(1):e000585. PubMed ID: 30713716 [TBL] [Abstract][Full Text] [Related]
19. Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway. Kerola AM; Sexton J; Wibetoe G; Rollefstad S; Crowson CS; Mars N; Kazemi A; Haavardsholm EA; Kvien TK; Semb AG Semin Arthritis Rheum; 2021 Oct; 51(5):1081-1088. PubMed ID: 34450506 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Han C; Robinson DW; Hackett MV; Paramore LC; Fraeman KH; Bala MV J Rheumatol; 2006 Nov; 33(11):2167-72. PubMed ID: 16981296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]